Page 22 - book
P. 22
Certificates: IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
List of GMP & ISO Certification
Revision No.: 17 Revision Date: 10.04.2023
No. Country Certification Code Inspected Line/ Product Name Issue Date Validity Date
AryoSeven 1.2 mg
Zytux 100 mg/10 ml & 500 mg/50ml
Etanercept
1 Russia GMP-02122/21/IR Dec. 2021 Dec. 2024
Rituximab
Altebrel 25 mg/0.5ml & 50 mg/1 ml
Eptacog alfa
2 Bulgaria (EMA) BG/GMP/2018/128 All product 31.07.2018 Dec. 2023
04.748.181/0009- DS Eptacog alfa, Etanercept, Rituximab,
3 Brazil 18.07.2022 18.07.2024
47 Trastuzumab
2022-1001/1 Altebrel 25 mg
2022-1005/1 AryoSeven 1.2 mg
4 Turkey 2022-1002/1 AryoTrust 150 mg 09.01.2022 11.02.2025
2022-1003/1 Stivant 100 mg/4 ml & 400 mg/16ml
2022-1004/1 Zytux 100 mg/10 ml & 500 mg/50ml
5 FPP-1402-01 Chemical & Biological Medicine (PFS) March 2023 March 2024
6 FPP-1401-71 Chemical & Biological Medicine (Vial) March 2023 March 2024
7 BIO-01-272 Temziva Vial January 2023 January 2025
8 BIO-00-225 Rituximab (Zytux, Vial) February 2022 February 2024
9 BIO-00-226 Etanercept (Altebrel, PFS) February 2022 February 2024
10 BIO-01-273 Recombinant FVII(AryoSeven, Vial) January 2023 January 2025
11 BIO-00-228 Bevacizumab (Stivant, Vial) February 2022 February 2024
IRAN
12 BIO-01-275 Recombinant FVII (AryoSeven RT, Vial) January 2023 January 2025
13 BIO-00-230 Denosumab 120 mg(Artenix, Vial) February 2022 February 2024
14 BIO-01-274 Denosumab 60 mg(Arylia, PFS) January 2023 January 2025
15 BIO-01-271 Trastuzumab (AryoTrust, Vial) January 2023 January 2025
16 BIO-00-233 Recombinant FVIII, Vial January 2022 January 2024
17 BIO-00-231 Vedolizumab Vial January 2022 January 2024
18 BIO-00-232 Panitumumab Vial January 2022 January 2024
19 IMQ (Italy) 1168.2019 General 03.07.2019 02.07.2025
21
you can find the rest of the product list on page 144